COMPANY

ProThera Biologics

HQ: Providence, RI source · protherabiologics.com ↗ · New England

Keywords: diagnostics

Location: Providence, RI · source · Oct 15, 2026

Profile checked Oct 10, 2026

23NIH grants

Funding and NIH signals

NIH award NIH awarded $954K (SBIR Phase II 5R44AI141283-06, continuation, notice May 13, 2026). NIH RePORTER 5R44AI141283-06 (May 13, 2026)
Evidence (1 event)
- May 13, 2026 · NIH RePORTER 5R44AI141283-06
  Organization: PROTHERA BIOLOGICS, LLC; City/State: PROVIDENCE, RI; Project number: 5R44AI141283-06; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-13; FY total cost (award amount): 954189; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

May 13, 2026 Grant Government grant — SBIR: $954,189 (annual award, as published), announced May 13, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 25, 2025 Grant Government grant — SBIR: $971,267 (annual award, as published), announced Apr 25, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 25, 2025 Grant Government grant — SBIR: $50,184 (annual award, as published), announced Apr 25, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

Funding

Last 2 years.

May 13, 2026 Government grant — SBIR: $954,189 (annual award, as published), announced May 13, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 25, 2025 Government grant — SBIR: $971,267 (annual award, as published), announced Apr 25, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 25, 2025 Government grant — SBIR: $50,184 (annual award, as published), announced Apr 25, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

NIH awards 23

Annual award amounts. Total $14.8M.

Apr 18, 2024 NIH award 2R44AI141283-04 FY2024: $987,396 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Rapid Test to Assist Therapy in Neonatal S source ↗
Sep 22, 2023 NIH award 1R43HD114348-01 FY2023: $378,272 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Inter-alpha Inhibitors in Experimental Nec source ↗
Sep 7, 2023 NIH award 2R44NS084575-04 FY2023: $2,776,920 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Inter-alpha Inhibitors in Hypoxic-Ischem source ↗
Mar 27, 2020 NIH award 5R44AI141283-03 FY2020: $862,493 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Rapid Test to Assist Therapy in Neonatal S source ↗
May 3, 2019 NIH award 4R44AI141283-02 FY2019: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Rapid Test to Assist Therapy in Neonatal source ↗
Aug 14, 2018 NIH award 1R44AI141283-01 FY2018: $166,522 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Rapid Test to Assist Therapy in Neonatal S source ↗
Jun 15, 2018 NIH award 5R44NS084575-03 FY2018: $941,149 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Inter-alpha Inhibitors in Hypoxic-Ischemic source ↗
Jun 9, 2017 NIH award 2R44NS084575-02A1 FY2017: $984,466 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Inter-alpha Inhibitors in Hypoxic-Ischem source ↗
Sep 16, 2015 NIH award 1R43AR066430-01A1 FY2015: $224,688 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Therapeutic Role of Inter-alpha Inhibito source ↗
Jun 17, 2014 NIH award 1R43NS084575-01A1 FY2014: $203,226 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Inter-alpha-inhibitors in Hypoxic-Ischem source ↗
Aug 13, 2013 NIH award 5R43HD069243-02 FY2013: $250,566 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Rapid detection of neonatal sepsis source ↗
Aug 22, 2012 NIH award 1R43HD069243-01A1 FY2012: $247,495 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Rapid detection of neonatal sepsis source ↗
May 24, 2012 NIH award 5R42AI062095-05 FY2012: $799,975 awarded for that fiscal year; activity R42 (STTR); PI OPAL, STEVEN M.; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Role of Inter-alpha Inhibitors in Anthr source ↗
Jun 9, 2011 NIH award 5R42AI062095-04 FY2011: $863,586 awarded for that fiscal year; activity R42 (STTR); PI OPAL, STEVEN M.; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Role of Inter-alpha Inhibitors in Anthr source ↗
Jun 2, 2010 NIH award 2R42AI062095-03A1 FY2010: $1,000,000 awarded for that fiscal year; activity R42 (STTR); PI OPAL, STEVEN M.; recipient as written: PROTHERA BIOLOGICS, LLC, PROVIDENCE, RI. Role of Inter-alpha Inhibitors in A source ↗
Aug 27, 2007 NIH award 1R43GM079071-01A1 FY2007: $170,547 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. Bioprocessing of Plasma Therapeutic source ↗
Jun 25, 2007 NIH award 5R44GM065667-03 FY2007: $983,869 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. THERAPEUTIC USE OF INTER-ALPHA INHIBI source ↗
Apr 24, 2007 NIH award 5R41AI062095-02 FY2007: $500,000 awarded for that fiscal year; activity R41 (STTR); PI OPAL, STEVEN M.; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. Role of Inter-alpha Inhibitors in source ↗
Apr 27, 2006 NIH award 1R41AI062095-01A2 FY2006: $500,000 awarded for that fiscal year; activity R41 (STTR); PI OPAL, STEVEN M.; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. Role of Inter-alpha Inhibitors i source ↗
Mar 11, 2005 NIH award 1U43CA110698-01 FY2005: $139,911 awarded for that fiscal year; activity U43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. Inter-alpha Inhibitors in Detecting C source ↗
Jun 14, 2004 NIH award 2R44GM065667-02 FY2004: $517,546 awarded for that fiscal year; activity R44 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. THERAPEUTIC USE OF INTER-ALPHA INHIBI source ↗
2003 NIH award 1R43GM068171-01 FY2003: $131,233 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. Predictive value of inter-alpha inhib source ↗
Apr 29, 2002 NIH award 1R43GM065667-01 FY2002: $143,105 awarded for that fiscal year; activity R43 (SBIR); PI LIM, YOW-PIN; recipient as written: PROTHERA BIOLOGICS, LLC, EAST PROVIDENCE, RI. Therapeutic Use of Inter-alpha Inhibi source ↗